5'-iodoindirubin has been researched along with indirubin-5-sulfonate in 1 studies
Studies (5'-iodoindirubin) | Trials (5'-iodoindirubin) | Recent Studies (post-2010) (5'-iodoindirubin) | Studies (indirubin-5-sulfonate) | Trials (indirubin-5-sulfonate) | Recent Studies (post-2010) (indirubin-5-sulfonate) |
---|---|---|---|---|---|
6 | 0 | 1 | 5 | 0 | 2 |
Protein | Taxonomy | 5'-iodoindirubin (IC50) | indirubin-5-sulfonate (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.4 | |
Insulin receptor | Homo sapiens (human) | 0.4 | |
Cyclin-dependent kinase 1 | Homo sapiens (human) | 0.04 | |
Cyclin-dependent kinase 4 | Homo sapiens (human) | 0.2667 | |
Cyclin-A2 | Homo sapiens (human) | 0.035 | |
Kit ligand | Homo sapiens (human) | 0.4 | |
G1/S-specific cyclin-D1 | Homo sapiens (human) | 0.3 | |
Cyclin-dependent kinase 2 | Homo sapiens (human) | 0.1784 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.4 | |
Cyclin-dependent-like kinase 5 | Homo sapiens (human) | 0.065 | |
Cyclin-dependent kinase 5 activator 1 | Homo sapiens (human) | 0.065 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Grundt, P; Jones-Brando, L; Krivogorsky, B; Yolken, R | 1 |
1 other study(ies) available for 5'-iodoindirubin and indirubin-5-sulfonate
Article | Year |
---|---|
Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.
Topics: Animals; Antiprotozoal Agents; Drugs, Chinese Herbal; Indoles; Isatis; Parasitic Sensitivity Tests; Quinazolines; Toxoplasma | 2008 |